TytoCare, an AI-first clinical enablement startup and a pioneer of remote physical examination technology featuring FDA-cleared medical devices, today raised a $25 million-plus growth round led by Insight Partners along with HOOP, OliveTree, OrbiMed, Qumra Capital, Qualcomm Ventures, and others.
The startup plans to use the fresh funds to expand its AI clinical algorithms pipeline, deepen payer and health system partnerships, and accelerate go-to-market efforts targeting chronic and serious disease populations — including cardiometabolic patients, those undergoing cancer treatment, and post-acute care transitions.
TytoCare’s SaMD AI algorithms, with the company’s remote physical examination technology featuring FDA-cleared medical devices, provide clinicians with clinical data and decision-support outputs across multiple examination modalities, including lung auscultation analysis to support evaluation of patients with cardiopulmonary conditions, cardiac screening signals, and dermatological assessment.
These capabilities position TytoCare as an end-to-end clinical enablement partner for health systems seeking to extend specialist-grade diagnostic rigor into the home.